References: Visual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban population: letter to the editor

Views

CrossRef citations to date

Altmetric

References

BasheerKMensahEKhanamTMinakaranNVisual outcomes of age-related macular degeneration patients undergoing intravitreal ranibizumab monotherapy in an urban populationClin Ophthalmol2015995996526060392
PubMedGoogle Scholar
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year resultsOphthalmology201211971388139822555112
PubMed Web of Science ®Google Scholar
RosenfeldPJShapiroHTuomiLMARINA and ANCHOR Study GroupsCharacteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trialsOphthalmology2011118352353020920825
PubMed Web of Science ®Google Scholar
BrownDMMichelsMKaiserPKRanibizumab versus verte porfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR studyOphthalmology20091161576519118696
PubMed Web of Science ®Google Scholar
ChakravarthyUHardingSPRogersCAIVAN study investigators. Alternative treatments to inhibit VEGF in age-related choroidal neovascularization: 2-year findings of the IVAN randomized controlled trialLancet201338299001258126723870813
PubMed Web of Science ®Google Scholar